BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15037696)

  • 1. Mortality and Parkinson disease: A community based study.
    Herlofson K; Lie SA; Arsland D; Larsen JP
    Neurology; 2004 Mar; 62(6):937-42. PubMed ID: 15037696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Modifying Effect of Age on Survival in Parkinson's Disease: A Population-Based Cohort Study.
    Peretz C; Rozani V; Giladi N; El-Ad B; Tsamir J; Hemo B; Gurevich T
    Neuroepidemiology; 2019; 53(1-2):13-19. PubMed ID: 31203291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease patients first treated at age 75 years or older: a comparative study.
    Peretz C; Chillag-Talmor O; Linn S; Gurevich T; El-Ad B; Silverman B; Friedman N; Giladi N
    Parkinsonism Relat Disord; 2014 Jan; 20(1):69-74. PubMed ID: 24183677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai.
    Zhang Y; Wang C; Wang Y; Xiao Q; Liu J; Ma J; Zhou H; Pan J; Tan Y; Chen S; Xu G; Wang G
    Parkinsonism Relat Disord; 2018 Oct; 55():75-80. PubMed ID: 29802079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and cancer incidence in patients with Parkinson's disease.
    Minami Y; Yamamoto R; Nishikouri M; Fukao A; Hisamichi S
    J Neurol; 2000 Jun; 247(6):429-34. PubMed ID: 10929271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population.
    Hobson P; Meara J; Ishihara-Paul L
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1093-8. PubMed ID: 20571039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study.
    Driver JA; Kurth T; Buring JE; Gaziano JM; Logroscino G
    Neurology; 2008 Apr; 70(16 Pt 2):1423-30. PubMed ID: 18413567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What predicts mortality in Parkinson disease?: a prospective population-based long-term study.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
    Neurology; 2010 Oct; 75(14):1270-6. PubMed ID: 20921512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality after total hip replacement: 0-10-year follow-up of 39,543 patients in the Norwegian Arthroplasty Register.
    Lie SA; Engesaeter LB; Havelin LI; Gjessing HK; Vollset SE
    Acta Orthop Scand; 2000 Feb; 71(1):19-27. PubMed ID: 10743987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Mortality of Parkinson's Disease in Estonia.
    Kadastik-Eerme L; Taba N; Asser T; Taba P
    Neuroepidemiology; 2019; 53(1-2):63-72. PubMed ID: 30991384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of Parkinson's disease survival in Israeli men and women, using health maintenance organization pharmacy data in a unique approach.
    Chillag-Talmor O; Giladi N; Linn S; Gurevich T; El-Ad B; Silverman B; Friedman N; Peretz C
    J Neurol; 2013 Jan; 260(1):62-70. PubMed ID: 22772304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dementia and survival in Parkinson disease: a 12-year population study.
    Buter TC; van den Hout A; Matthews FE; Larsen JP; Brayne C; Aarsland D
    Neurology; 2008 Mar; 70(13):1017-22. PubMed ID: 18362281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality after traumatic spinal cord injury: 50 years of follow-up.
    Hagen EM; Lie SA; Rekand T; Gilhus NE; Gronning M
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):368-73. PubMed ID: 19726408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of death in a community-based study of Parkinson's disease.
    Beyer MK; Herlofson K; Arsland D; Larsen JP
    Acta Neurol Scand; 2001 Jan; 103(1):7-11. PubMed ID: 11153892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in mortality among patients admitted with affective disorders in North Norway: a 33-year prospective register study.
    Høye A; Nesvåg R; Reichborn-Kjennerud T; Jacobsen BK
    Bipolar Disord; 2016 May; 18(3):272-81. PubMed ID: 27226265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient characteristics, MRI examination, and dopaminergic drug response in clinical possible Parkinson's disease.
    Larsen JP; Odegaard H; Tandberg E; Hødnebø A; Aarsland D
    J Geriatr Psychiatry Neurol; 1996 Oct; 9(4):157-63. PubMed ID: 8970007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized mortality ratio and seasonal fluctuations of mortality in Parkinson's disease.
    Hristova DR
    Folia Med (Plovdiv); 2009; 51(2):40-5. PubMed ID: 19670539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General and cancer mortality in a large cohort of Italian alcoholics.
    Saieva C; Bardazzi G; Masala G; Quartini A; Ceroti M; Iozzi A; Gelain E; Querci A; Allamani A; Palli D
    Alcohol Clin Exp Res; 2012 Feb; 36(2):342-50. PubMed ID: 22085221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in Parkinson's disease and its association with dementia and depression.
    Hughes TA; Ross HF; Mindham RH; Spokes EG
    Acta Neurol Scand; 2004 Aug; 110(2):118-23. PubMed ID: 15242420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
    Weintraub D; Chiang C; Kim HM; Wilkinson J; Marras C; Stanislawski B; Mamikonyan E; Kales HC
    JAMA Neurol; 2016 May; 73(5):535-41. PubMed ID: 26999262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.